scholarly journals Hybrid Cognitive-Behavioral Therapy Intervention for Adolescents With Co-Occurring Migraine and Insomnia: A Single-Arm Pilot Trial

2018 ◽  
Vol 58 (7) ◽  
pp. 1060-1073 ◽  
Author(s):  
Emily F. Law ◽  
See Wan Tham ◽  
Rachel V. Aaron ◽  
Joanne Dudeney ◽  
Tonya M. Palermo
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Behavioral Therapy ◽  
Pilot Trial ◽  
Cognitive Behavioral ◽  
Therapy Intervention

A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia

2001 ◽  
Vol 3 (4) ◽  
pp. 397-403 ◽  
Author(s):  
A. Eden Evins ◽  
Virginia K. Mays ◽  
Nancy A. Rigotti ◽  
Thelma Tisdale ◽  
Corinne Cather ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Cognitive Behavioral Therapy ◽  
Behavioral Therapy ◽  
Pilot Trial ◽  
Cognitive Behavioral

scholarly journals Cognitive behavioral therapy for insomnia among young adults who are actively drinking: a randomized pilot trial

SLEEP ◽  
2020 ◽  
Author(s):  
Mary Beth Miller ◽  
Chelsea B Deroche ◽  
Lindsey K Freeman ◽  
Chan Jeong Park ◽  
Nicole A Hall ◽  
...  
Keyword(s):  
Young Adults ◽  
Alcohol Use ◽  
Cognitive Behavioral Therapy ◽  
Binge Drinking ◽  
Behavioral Therapy ◽  
Pilot Trial ◽  
Cognitive Behavioral ◽  
Wrist Actigraphy ◽  
Insomnia Severity

Abstract Study Objectives More than half of young adults at risk for alcohol-related harm report symptoms of insomnia. Insomnia symptoms, in turn, have been associated with alcohol-related problems. Yet one of the first-line treatments for insomnia (Cognitive Behavioral Therapy for Insomnia or CBT-I) has not been tested among individuals who are actively drinking. This study tested (1) the feasibility and short-term efficacy of CBT-I among binge-drinking young adults with insomnia and (2) improvement in insomnia as a predictor of improvement in alcohol use outcomes. Methods Young adults (ages 18–30 years, 75% female, 73% college students) who met criteria for Insomnia Disorder and reported 1+ binge drinking episode (4/5+ drinks for women/men) in the past month were randomly assigned to 5 weekly sessions of CBT-I (n = 28) or single-session sleep hygiene (SH, n = 28). All participants wore wrist actigraphy and completed daily sleep surveys for 7+ days at baseline, posttreatment, and 1-month follow-up. Results Of those randomized, 43 (77%) completed posttreatment (19 CBT-I, 24 SH) and 48 (86%) completed 1-month follow-up (23 CBT-I, 25 SH). CBT-I participants reported greater posttreatment decreases in insomnia severity than those in SH (56% vs. 32% reduction in symptoms). CBT-I did not have a direct effect on alcohol use outcomes; however, mediation models indicated that CBT-I influenced change in alcohol-related consequences indirectly through its influence on posttreatment insomnia severity. Conclusions CBT-I is a viable intervention among individuals who are actively drinking. Research examining improvement in insomnia as a mechanism for improvement in alcohol-related consequences is warranted. Trial Registration U.S. National Library of Medicine, https://clinicaltrials.gov/ct2/show/NCT03627832, registration #NCT03627832

scholarly journals A pilot study of an exercise & cognitive behavioral therapy intervention for epithelial ovarian cancer patients

2013 ◽  
Vol 6 (1) ◽  
pp. 21 ◽  
Author(s):  
Shalini H Moonsammy ◽  
Crissa L Guglietti ◽  
Daniel Santa Mina ◽  
Sarah Ferguson ◽  
Jennifer L Kuk ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Pilot Study ◽  
Cognitive Behavioral Therapy ◽  
Epithelial Ovarian Cancer ◽  
Cancer Patients ◽  
Behavioral Therapy ◽  
Cognitive Behavioral ◽  
Therapy Intervention

scholarly journals Optimizing Smartphone-Delivered Cognitive Behavioral Therapy for Body Dysmorphic Disorder Using Passive Smartphone Data: Initial Insights From an Open Pilot Trial

10.2196/16350 ◽  
2020 ◽  
Vol 8 (6) ◽  
pp. e16350
Author(s):  
Hilary Weingarden ◽  
Aleksandar Matic ◽  
Roger Garriga Calleja ◽  
Jennifer L Greenberg ◽  
Oliver Harrison ◽  
...  
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Symptom Severity ◽  
Body Dysmorphic Disorder ◽  
Behavioral Therapy ◽  
Pilot Trial ◽  
Cognitive Behavioral ◽  
Sensor Data ◽  
Mobility Patterns ◽  
Insight Into ◽  
Open Pilot

Background Smartphone-delivered cognitive behavioral therapy (CBT) is becoming more common, but research on the topic remains in its infancy. Little is known about how people typically engage with smartphone CBT or which engagement and mobility patterns may optimize treatment. Passive smartphone data offer a unique opportunity to gain insight into these knowledge gaps. Objective This study aimed to examine passive smartphone data across a pilot course of smartphone CBT for body dysmorphic disorder (BDD), a psychiatric illness characterized by a preoccupation with a perceived defect in physical appearance, to inform hypothesis generation and the design of subsequent, larger trials. Methods A total of 10 adults with primary diagnoses of BDD were recruited nationally and completed telehealth clinician assessments with a reliable evaluator. In a 12-week open pilot trial of smartphone CBT, we initially characterized natural patterns of engagement with the treatment and tested how engagement and mobility patterns across treatment corresponded with treatment response. Results Most participants interacted briefly and frequently with smartphone-delivered treatment. More frequent app usage (r=–0.57), as opposed to greater usage duration (r=–0.084), correlated strongly with response. GPS-detected time at home, a potential digital marker of avoidance, decreased across treatment and correlated moderately with BDD severity (r=0.49). Conclusions The sample was small in this pilot study; thus, results should be used to inform the hypotheses and design of subsequent trials. The results provide initial evidence that frequent (even if brief) practice of CBT skills may optimize response to smartphone CBT and that mobility patterns may serve as useful passive markers of symptom severity. This is one of the first studies to examine the value that passively collected sensor data may contribute to understanding and optimizing users’ response to smartphone CBT. With further validation, the results can inform how to enhance smartphone CBT design.

scholarly journals Comparative Effectiveness of Cheonwangbosimdan (Tian Wang Bu Xin Dan) Versus Cognitive-Behavioral Therapy for Insomnia in Cancer Patients: A Randomized, Controlled, Open-Label, Parallel-Group, Pilot Trial

2020 ◽  
Vol 19 ◽  
pp. 153473542093564
Author(s):  
Sun-Young Moon ◽  
Ui Min Jerng ◽  
O-Jin Kwon ◽  
So-Young Jung ◽  
Jee Young Lee ◽  
...  
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Cancer Patients ◽  
Group Performance ◽  
Behavioral Therapy ◽  
Pilot Trial ◽  
Eastern Cooperative Oncology Group ◽  
Cognitive Behavioral ◽  
Control Group ◽  
Group Score ◽  
Significant Difference

Cancer patients have a 2 times higher prevalence of insomnia than healthy populations and cancer-related insomnia has received minimal attention while insomnia can aggravate the rehabilitation of cancer patients. Cheonwangbosimdan is a Korean herbal medicine generally used to relieve sleep deprivation, however, few studies presented the effects of Cheonwangbosimdan on cancer-related insomnia. The purpose of study is to examine the feasibility of Cheonwangbosimdan treatments for cancer patients. Twenty-two participants were allocated into a Cheonwangbosimdan or cognitive-behavioral therapy for insomnia (CBT-I) control group by equal number. The intervention group took Cheonwangbosimdan liquid once in a day and attend visits once a week for 4 weeks. The CBT-I group underwent individualized behavioral therapy 4 times in 4 weeks. The primary outcome is changes in the Insomnia Severity Index (ISI) from baseline to the end of the trial. Responses to the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), Zung Self-Rating Anxiety Scale (SAS), Brief Fatigue Inventory (BFI), Euroqol-5 Dimensions-5 Levels (EQ-5D-5L), and Eastern Cooperative Oncology Group Performance Status (ECOG-PS) were secondary outcomes used to evaluate the quality of sleep. Outcomes were measured at a follow-up visit (visit 5) in the fifth week of the trial. There is no difference between 2 groups, but both groups showed tendency to alleviate cancer insomnia symptoms. SAS-K showed significant difference between the 2 groups (P < .001), as treatment group score was highly lowered than control group score. The study can contribute to more attentive care for insomnia in cancer patients.

Sign in / Sign up

Export Citation Format

Share Document